Skip to main content
. 2018 Jul 17;20:188–196. doi: 10.1016/j.nicl.2018.07.014

Fig. 1.

Fig. 1

Classification results bvFTD model.

Box and scatter plot of each subject's bvFTD probability score on a scale from 0 (representing control) to 1 (representing bvFTD patient) after application of the bvFTD model. Groups are defined by carrier status (Fig. 1A) and genetic status (Fig. 1B). Probability scores were not significantly different for carriers and controls (p = 0.22), and did not differ between the four genetic groups (p = 0.60). Probability score results of the bvFTD patients and controls on which the bvFTD model was cross-validated were added for reference (Fig. 1C, data courtesy of Bouts et al. (2018) (Bouts et al., 2018)). Abbreviations: C9orf72: chromosome 9 open reading frame 72; GRN: progranulin; MAPT: microtubule-associated protein tau.